JPH1095778A5 - - Google Patents

Info

Publication number
JPH1095778A5
JPH1095778A5 JP1997232472A JP23247297A JPH1095778A5 JP H1095778 A5 JPH1095778 A5 JP H1095778A5 JP 1997232472 A JP1997232472 A JP 1997232472A JP 23247297 A JP23247297 A JP 23247297A JP H1095778 A5 JPH1095778 A5 JP H1095778A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
substituted phenyl
ocoar
oso2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997232472A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1095778A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH1095778A publication Critical patent/JPH1095778A/ja
Publication of JPH1095778A5 publication Critical patent/JPH1095778A5/ja
Ceased legal-status Critical Current

Links

JP9232472A 1996-08-29 1997-08-28 ベンゾ［ｂ］チオフェン化合物、中間体、製造法、組成物及び使用方法 Ceased JPH1095778A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2512496P 1996-08-29 1996-08-29
US60/025124 1996-08-29

Publications (2)

Publication Number Publication Date
JPH1095778A JPH1095778A (ja) 1998-04-14
JPH1095778A5 true JPH1095778A5 (enExample) 2005-05-26

Family

ID=21824170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9232472A Ceased JPH1095778A (ja) 1996-08-29 1997-08-28 ベンゾ［ｂ］チオフェン化合物、中間体、製造法、組成物及び使用方法

Country Status (7)

Country Link
US (4) US5843965A (enExample)
EP (1) EP0827959B1 (enExample)
JP (1) JPH1095778A (enExample)
AT (1) ATE255574T1 (enExample)
CA (1) CA2214072C (enExample)
DE (1) DE69726513T2 (enExample)
ES (1) ES2212048T3 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
AU735703B2 (en) * 1997-06-10 2001-07-12 Karo Bio Ab Estrogen receptor ligands
WO1999051587A1 (en) * 1998-04-01 1999-10-14 Ono Pharmaceutical Co., Ltd. Fused thiophene derivatives and drugs containing the same as the active ingredient
PL343438A1 (en) * 1998-04-08 2001-08-13 Lilly Co Eli Pulmonary and nasal delivery of raloxifene
US6087378A (en) * 1998-10-13 2000-07-11 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
JP2004531559A (ja) * 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
WO2002094788A1 (en) * 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
EP3192795B1 (en) 2012-10-24 2020-12-02 The Board of Trustees of the University of Illionis Compositions and methods for treating estrogen-related medical disorders
ES2774935T3 (es) 2012-10-24 2020-07-23 Univ Illinois Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno
CN114516853A (zh) * 2022-02-24 2022-05-20 青岛科技大学 一种含药物分子的苯并噻吩衍生物的电催化制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1300575B (de) * 1965-05-21 1969-08-07 Bristol Myers Co Benzo[b]thiophene
US3394125A (en) * 1965-10-23 1968-07-23 Bristol Myers Co 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
GB2097788B (en) * 1981-04-03 1985-04-24 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4358593A (en) * 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
JPH02501301A (ja) * 1987-09-25 1990-05-10 チバ‐ガイギー　アクチェンゲゼルシャフト ４‐（トリアルキルベンジル）‐ピペラジニル化合物のジアシル誘導体
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
US5492921A (en) * 1994-09-20 1996-02-20 Eli Lilly And Company Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation
IL132952A (en) * 1995-02-28 2002-02-10 Lilly Co Eli Benzothiophene derivatives
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US6395755B1 (en) * 1995-03-10 2002-05-28 Eli Lilly And Company Benzothiophene pharmaceutical compounds
US5728724A (en) * 1995-08-17 1998-03-17 Eli Lilly And Company Benzothiophene compounds
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2002513793A5 (enExample)
JPH1087577A5 (enExample)
NO307929B1 (no) Naftylforbindelser, anvendelse av disse for fremstilling av et farmasøytisk preparat, mellomprodukter, sammensetninger inneholdende disse forbindelser eller mellomprodukter, samt fremgangsmÕte for fremstilling av forbindelsene
JPH1095778A5 (enExample)
JP2005508962A5 (enExample)
CA2373117A1 (en) 13-methyl-erythromycin derivatives
JP2002510633A5 (enExample)
JP2003503449A5 (enExample)
JP2004504323A5 (enExample)
JP2002506864A5 (enExample)
CA2440014A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
JP2004525178A5 (enExample)
DE69707611D1 (de) Dihydronaphthalen- und Naphthalenderivate, Zwischenverbindungen, Zusammensetzungen und deren Herstellungsverfahren
JPH10130212A5 (enExample)
JP2008509113A5 (enExample)
JPH10130211A5 (enExample)
EP0826679A3 (en) Naphthyl compounds, intermediates, compositions, and method of use
JPH1087578A5 (enExample)
JP2003509494A5 (enExample)
JP2002535406A5 (enExample)
SI1052245T1 (en) High purity (1R, 2S, 4R)-(-)-2-((2'-(N,N-dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri-(methyl)-bicyclo(2.2.1)heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them
RU97106107A (ru) Способ минимизации гистеротрофного эффекта тамоксифена и аналогов тамоксифена
AU3686295A (en) A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
JPH10130260A5 (enExample)
KR920019760A (ko) 2-아미노피리미딘-4- 카르복시아미드 유도체, 그의 제법 및 치료에의 이용